Article Figures & Data
Tables
Object Drug Precipitant Drug Correct Answer for DR Scores Correct Response % Baseline Correct Response % Posttest Correct Response % 1-Year Absolute Difference in Scores Between: Baseline and Posttest Post and 1-Year Baseline and 1-Year Nitroglycerine Sildenafil I 97 100 100 +3 0 +3 Warfarin Sulfamethoxazole/trimethoprim I 94 97 97 +3 0 +3 Acetaminophen/codeine Amoxicillin NI 91 100 100 +9 0 +9 Warfarin Naproxen I 82 100 97 +18 −3 +15 Warfarin Amiodarone I 76 100 88 +24 −12 +12 Warfarin Fluconazole I 76 97 82 +21 −15 +6 Digoxin Amiodarone I 76 88 94 +12 +6 +18 Carbamazepine Clarithromycin I 65 97 94 +32 −3 +29 Warfarin Gemfibrozil I 59 97 71 +38 −26 +12 Simvastatin Itraconazole I 56 97 91 +41 −6 +35 Digoxin Itraconazole I 56 91 88 +35 −3 +32 Digoxin Clarithromycin I 53 97 79 +44 −18 +26 Digoxin Sildenafil NI 44 91 100 +47 +9 +56 Metformin Erythromycin NI 38 88 97d +50 +9 +59 Warfarin Digoxin NI 9 79 88 +70 +9 +79 Abbreviations: DR = DDI Recognition; I = Interaction; NI = No Interaction
Object Drug Precipitant Drug Correct Answer for MS Scores Correct Response, % Baseline Correct Response, % Post Test Correct Response, % 1-Year Absolute Difference in Scores Between: Baseline and Post Post and 1-Year Baseline and 1-Year Nitroglycerine Sildenafil AC 94 100 100 +6 0 +6 Warfarin Sulfamethoxazole/trimethoprim UAC 26 88 56 +62 −32 +30 Acetaminophen/codeine Amoxicillin NI 91 100 100 +9 0 +9 Warfarin Naproxen UAC 24 91 38 +67 −53 +14 Warfarin Amiodarone TP 50 68 59 +18 −9 +9 Warfarin Fluconazole UAC 32 91 41 +59 −50 +9 Digoxin Amiodarone TP 21 82 44 +61 −38 +23 Carbamazepine Clarithromycin TP 50 85 41 +35 −44 −9 Warfarin Gemfibrozil UAC 18 91 32 +73 −59 +14 Simvastatin Itraconazole UAC 24 68 53 +44 −15 +29 Digoxin Itraconazole TP 29 74 41 +45 −33 +12 Digoxin Clarithromycin TP 29 91 53 +62 −38 +24 Digoxin Sildenafil NI 44 91 59 +47 −32 +15 Metformin Erythromycin NI 38 88 59 +50 −29 +21 Warfarin Digoxin NI 9 79 44 +70 −35 +35 Abbreviations: MS = DDI Management Strategy; AC = Avoid Combination; UAC = Usually Avoid Combination; TP = Take Precautions; NI = No Interaction.
- Table 3.
Comparison of Drug-Drug Interaction Knowledge Between Students Who Presented at Least One DDI Vignette and Those Who Did Not Complete Any
Case Presented Correct DR (%) CV (n = 18) Correct DR (%) No CV (n = 16) P Correct MS (%) CV (n = 18) Correct MS (%) No CV n = 16 P Nitroglycerine + sildenafil 18 (100) 16 (100) N/A 18 (100) 16 (100) N/A Warfarin + sulfamethoxazole/trimethoprim 18 (100) 15 (94) 0.28 12 (67) 7 (44) 0.19 Warfarin + naproxen 17 (94) 16 (100) 0.34 4 (22) 9 (56) 0.045 Warfarin + amiodarone 16 (89) 14 (88) 0.90 10 (56) 10 (63) 0.69 Warfarin + fluconazole 15 (83) 13 (81) 0.88 9 (50) 5 (31) 0.28 Digoxin + amiodarone 17 (94) 15 (94) 0.94 9 (50) 6 (38) 0.47 Carbamazepine + clarithromycin 17 (94) 15 (94) 0.94 8 (44) 6 (38) 0.69 Warfarin + gemfibrozil 15 (83) 9 (56) 0.80 8 (44) 3 (19) 0.11 Simvastatin + itraconazole 17 (94) 14 (88) 0.48 13 (72) 5 (31) 0.021 Digoxin + itraconazole 16 (89) 14 (88) 0.90 8 (44) 6 (38) 0.69 Digoxin + clarithromycin 15 (83) 12 (75) 0.55 11 (61) 7 (44) 0.31 Abbreviations : DR = DDI Recognition; MS = DDI Management Strategy; CV = Case Vignette
Characteristic No. (%), N = 141 Health Care Professionals Attending Pharmacists 119 (84) Others 55 (39) Physicians 18 (13) Nurse Practitioners 4 (3) Setting Hospital acute care 53 (38) Community pharmacy 33 (23) Other 16 (11) Ambulatory care pharmacy 14 (10) Hospital pharmacy 13 (9) Community health center 6 (4) Managed care 3 (2) Office-based practice (group) 3 (2) Subject of Vignette Warfarin + sulfamethoxazole/trimethoprim 24 (17) Warfarin + fluconazole 22 (16) Warfarin + amiodarone 18 (13) Simvastatin + itraconazole 17 (12) Warfarin + naproxen 16 (11) Carbamazepine + clarithromycin 15 (11) Warfarin + gemfibrozil 9 (6) Nitroglycerine + sildenafil 8 (6) Digoxin + amiodarone 7 (5) Digoxin + clarithromycin 3 (2) Digoxin + itraconazole 2 (1)